felin
infecti
periton
fip
felin
coronavirusinduc
fatal
diseas
domest
wild
cat
sever
studi
investig
potenti
treatment
fip
howev
report
agent
exhibit
therapeut
effect
recent
chloroquin
report
antivir
effect
investig
whether
chloroquin
use
treat
fip
vitro
vivo
demonstr
chloroquin
inhibitori
effect
replic
fipv
antiinflammatori
effect
vitro
vivo
studi
use
cat
experiment
induc
fip
clinic
score
chloroquinetreat
group
better
chloroquineuntr
group
howev
alanin
aminotransferas
level
increas
chloroquinetr
group
necessari
investig
possibl
fip
treatment
combin
chloroquin
agent
coronavirus
caus
diseas
respiratori
digest
nervou
system
mammal
bird
sever
acut
respiratori
syndrom
coronaviru
sarscov
newli
identifi
pathogen
fatal
respiratori
diseas
ksiazek
et
al
new
coronaviru
speci
isol
variou
anim
includ
human
recent
suggest
coronaviru
may
transmit
anim
human
et
al
felin
infecti
periton
viru
fip
viru
fipv
felin
coronaviru
fcov
famili
coronavirida
caus
fatal
diseas
call
fip
wild
domest
cat
speci
cat
develop
fip
affect
sever
organ
includ
liver
lung
spleen
central
nervou
system
form
lesion
accompani
necrosi
pyogen
granulomat
inflamm
pedersen
cat
pleural
effus
ascit
fluid
accumul
monocyt
macrophag
monocytesmacrophag
play
import
role
pathogenesi
fip
report
viru
replic
monocytesmacrophag
induc
interleukin
il
tumor
necrosi
factor
tnf
product
regan
et
al
takano
et
al
takano
et
al
fipv
replic
cytokin
product
enhanc
monocytesmacrophag
inocul
fipv
presenc
antifipv
antibodi
antibodydepend
enhanc
ade
hohdatsu
et
al
corapi
et
al
olsen
et
al
phenomenon
ade
involv
aggrav
patholog
fip
pedersen
boyl
takano
et
al
past
forti
year
sever
studi
investig
potenti
treatment
fip
hartmann
ritz
antivir
immunostimul
immunosuppress
drug
experiment
use
treatment
fip
none
exhibit
suffici
therapeut
effect
sever
agent
significantli
inhibit
fcov
replic
vitro
identifi
balzarini
et
al
barlough
shacklett
hsieh
et
al
kim
et
al
takano
et
al
howev
whether
agent
exhibit
therapeut
effect
cat
fip
investig
antimalari
drug
chloroquin
report
inhibit
replic
human
immunodefici
viru
hiv
influenza
viru
sarscov
human
coronaviru
kono
et
al
murray
et
al
savarino
et
al
vincent
et
al
yan
et
al
chloroquin
also
use
treat
immunemedi
inflammatori
disord
karr
et
al
et
al
lesiak
et
al
fip
viral
infect
caus
immunemedi
inflammatori
diseas
basi
find
chloroquin
may
effect
therapeut
drug
fip
investig
whether
chloroquin
inhibit
fipv
replic
vitro
fipvinduc
ade
activ
monocyt
furthermor
investig
effect
chloroquin
cat
experiment
induc
fip
feli
catu
whole
cell
grown
eagl
minimum
essenti
medium
contain
medium
fetal
calf
serum
fc
antibiot
felin
monocyt
cultur
rpmi
medium
contain
fc
antibiot
strain
fipv
grown
cell
strain
fipv
suppli
dr
mc
horzinek
utrecht
univers
mab
use
present
studi
recogn
spike
protein
type
ii
fipv
demonstr
immunoblot
report
mab
exhibit
neutral
activ
cell
enhanc
activ
felin
monocytesmacrophag
depend
reaction
condit
hohdatsu
et
al
felin
monocyt
isol
specif
pathogenfre
spf
cat
previous
describ
dewerchin
et
al
confluent
cell
monolay
cultur
medium
contain
chloroquin
wako
japan
multipl
h
wash
fipv
strain
tcid
ad
cultur
adsorb
cell
h
presenc
chloroquin
wash
cell
cultur
medium
contain
chloroquin
cultur
supernat
collect
day
experi
use
felin
monocyt
spf
cat
perform
follow
felin
monocyt
cell
cultur
medium
multipl
h
wash
fipv
strain
tcid
react
without
mab
ad
cultur
adsorb
cell
h
presenc
chloroquin
wash
cell
cultur
medium
contain
chloroquin
cultur
supernat
cell
collect
day
viru
titer
cultur
supernat
tcid
calcul
method
reedmuench
cell
use
measur
tnfa
mrna
fcov
n
gene
evalu
cytotox
effect
chloroquin
felin
cell
cell
viabil
measur
assay
describ
takano
et
al
percent
viabil
calcul
use
follow
formula
cell
viabil
od
chloroquinetr
cellsod
chloroquineuntr
cell
fipv
strain
tcid
ad
cultur
adsorb
cell
h
wash
cell
cultur
medium
contain
chloroquin
cultur
supernat
collect
day
experi
use
felin
monocyt
spf
cat
perform
follow
fipv
strain
tcid
react
without
mab
ad
cultur
adsorb
felin
monocyt
h
wash
cell
cultur
medium
contain
chloroquin
cultur
supernat
cell
collect
day
experi
use
felin
monocyt
cat
fip
fip
cat
perform
follow
felin
monocyt
cultur
medium
contain
chloroquin
cultur
supernat
cell
collect
day
viru
titer
cultur
supernat
tcid
calcul
cell
use
measur
cytokin
mrna
fcov
n
gene
rna
isol
cdna
prepar
perform
employ
method
takano
et
al
determin
felin
cytokin
mrna
fcov
n
gene
express
level
cdna
amplifi
pcr
use
specif
primer
shown
tabl
pcr
perform
use
method
takano
et
al
band
densiti
quantifi
appropri
uv
exposur
video
densitometri
use
imag
j
softwar
nih
usa
cytokin
mrna
fcov
n
gene
quantit
analyz
term
rel
densiti
valu
mrna
housekeep
gene
gapdh
nine
spf
cat
randomli
assign
three
experiment
group
accord
experiment
schedul
indic
fig
group
chloroquin
mgkg
subcutan
administ
everi
day
day
fipv
inocul
strain
fipv
tcid
ml
inocul
oral
cat
group
b
hank
balanc
salt
solut
hbss
subcutan
administ
everi
day
day
fipv
inocul
strain
fipv
tcid
ml
inocul
oral
cat
hbss
administr
complet
day
fipv
inocul
chloroquin
mgkg
subcutan
administ
everi
day
thereaft
instead
hbss
group
c
hbss
subcutan
administ
everi
day
day
fipv
inocul
strain
fipv
tcid
ml
inocul
oral
cat
one
anim
group
c
die
unexpectedli
challeng
fipv
exclud
studi
cat
check
daili
clinic
sign
measur
bodi
temperatur
weight
fip
diagnos
confirm
upon
postmortem
examin
reveal
periton
pleural
effus
pyogranuloma
major
organ
evalu
condit
cat
monitor
karnofski
score
karnofski
score
calcul
refer
report
hartmann
kuffer
ritz
et
al
protocol
experi
present
tabl
cytotox
effect
chloroquin
cell
monocyt
cell
viabil
evalu
assay
chloroquin
blood
ml
collect
cat
use
syring
coat
edta
use
collect
sampl
blood
biochemistri
hematolog
analys
half
millilit
blood
sampl
centrifug
supernat
use
plasma
sampl
blood
biochemistri
remaind
blood
sampl
use
hematolog
analys
heparin
blood
ml
dilut
phosphatebuff
salin
pb
subject
ficollhypaqu
follow
inocul
fipv
h
supernat
remov
cell
treat
chloroquin
prepost
treatment
post
treatment
group
day
viru
titer
cell
cultur
supernat
measur
n
b
monocyt
cultur
chloroquin
h
prepost
treatment
group
post
treatment
group
follow
inocul
fipv
h
supernat
remov
cell
treat
chloroquin
prepost
treatment
post
treatment
group
day
viru
titer
felin
primari
monocyt
cultur
supernat
measur
n
p
vs
without
chloroquin
lm
p
vs
without
chloroquin
lm
monocyt
cultur
chloroquin
h
prepost
treatment
group
black
bar
none
group
white
bar
post
treatment
group
gray
bar
follow
treatment
reaction
mixtur
fipv
antifipv
antibodi
fipv
mab
h
supernat
remov
cell
treat
chloroquin
prepost
treatment
post
treatment
group
none
group
day
viru
titer
cell
cultur
supernat
c
intracellular
fcov
n
gene
level
measur
fcov
n
gene
quantit
analyz
term
rel
densiti
valu
mrna
housekeep
gene
gapdh
n
chloroquin
prepost
treatment
post
treatment
group
none
group
day
intracellular
tnfa
mrna
level
measur
cytokin
mrna
quantit
analyz
term
rel
densiti
valu
mrna
housekeep
gene
gapdh
n
densiti
gradient
centrifug
min
pbmc
layer
collect
wash
twice
pb
resuspend
growth
medium
cellsml
statist
analysi
data
two
group
analyz
student
test
multipl
group
analyz
oneway
anova
effect
chloroquin
fipv
infect
cell
spf
catderiv
monocyt
investig
cytotox
effect
chloroquin
felin
cell
show
tabl
cell
fipv
replic
inhibit
chloroquin
concentrationdepend
manner
prepost
post
treatment
group
fig
similarli
concentrationdepend
inhibit
viral
replic
note
felin
monocyt
treat
chloroquin
fig
howev
antivir
effect
chloroquin
slightli
lower
post
treatment
group
prepost
treatment
group
effect
chloroquin
antibodydepend
enhanc
fipv
infect
monocyt
investig
viru
titer
intracellular
express
level
fipv
n
gene
significantli
higher
cultur
supernat
monocyt
inocul
mixtur
fipv
mab
monocyt
cultur
fipv
alon
fig
b
monocyt
inocul
mixtur
fipv
mab
viru
titer
significantli
lower
post
prepost
treatment
group
none
group
fig
intracellular
express
level
fipv
n
gene
significantli
lower
prepost
treatment
group
none
group
fig
intracellular
tnfa
mrna
express
level
significantli
higher
monocyt
inocul
mixtur
fipv
mab
monocyt
cultur
medium
fipv
alon
fig
monocyt
inocul
mixtur
fipv
mab
tnfa
mrna
express
level
significantli
lower
prepost
treatment
group
none
group
fig
howev
signific
differ
mrna
express
level
note
post
treatment
none
group
fig
influenc
chloroquin
cytokin
mrna
fcov
n
gene
express
investig
monocyt
cat
fip
tnfa
mrna
express
level
significantli
higher
increas
level
fcov
n
gene
express
monocyt
cat
fip
monocyt
spf
cat
fig
mrna
express
level
significantli
lower
monocyt
cat
fip
cultur
medium
contain
lm
chloroquin
monocyt
cultur
without
chloroquin
fig
howev
signific
differ
note
level
fcov
n
gene
express
without
chloroquin
base
vitro
result
therapeut
effect
chloroquin
investig
use
cat
experiment
induc
fip
experi
perform
follow
schedul
shown
fig
fcov
n
gene
cytokin
mrna
detect
clinic
paramet
measur
fipv
inocul
onset
fip
pbmc
collect
day
fipv
inocul
viral
mrna
express
level
measur
viral
mrna
express
level
measur
semiquantit
rtpcr
day
viral
mrna
express
level
slightli
lower
group
group
b
c
day
viral
mrna
express
level
slightli
lower
group
b
chloroquinetr
group
group
c
fig
inflammatori
cytokin
mrna
express
level
pbmc
day
fipv
inocul
measur
ratio
mrna
express
level
inocul
determin
fig
inflammatori
cytokin
mrna
express
ratio
slightli
lower
group
b
chloroquinetr
group
group
c
chang
bodi
temperatur
fipv
inocul
measur
tabl
major
chang
bodi
temperatur
note
group
lymphocyt
neutrophil
count
peripher
blood
decreas
cat
day
fipv
inocul
tabl
level
reduct
smaller
chloroquinetr
group
group
c
increas
total
protein
tp
alkalin
phosphatas
alp
gammaglutamyl
transferas
ggt
direct
bilirubin
dbil
level
smaller
group
group
tabl
hand
alanin
aminotransferas
alt
level
increas
chloroquinetr
group
clinic
condit
cat
group
evalu
use
karnofski
score
score
high
chloroquinetr
group
tabl
mean
number
surviv
day
group
b
c
respect
unfortun
one
anim
group
c
die
challeng
fipv
statist
signific
shown
differ
cytokin
mrna
level
ratio
control
tnf
fig
tnfa
mrna
express
level
pbmc
fipvinfect
cat
treat
chloroquin
inocul
fipv
day
pbmc
collect
cat
intracellular
tnfa
mrna
level
measur
cytokin
mrna
quantit
analyz
term
rel
densiti
valu
mrna
housekeep
gene
gapdh
data
express
ratio
control
valu
day
inocul
fipv
chloroquinetreat
group
group
c
day
surviv
report
chloroquin
use
treatment
viral
infect
kono
et
al
murray
et
al
savarino
et
al
vincent
et
al
yan
et
al
howev
studi
obtain
vitro
experi
studi
investig
antivir
effect
chloroquin
use
experiment
anim
pallist
et
al
vigerust
mcculler
investig
effect
chloroquin
therapeut
drug
fip
vitro
vivo
fipv
enhanc
prolifer
monocyt
treat
reaction
mixtur
fipv
antifipv
antibodi
contrast
viru
prolifer
inhibit
chloroquinetr
monocyt
ie
chloroquin
inhibit
fipvinduc
ade
activ
monocyt
addit
signific
inhibitori
effect
fipv
gene
express
note
cell
prepost
treatment
contrast
signific
inhibitori
effect
note
cell
post
treatment
treatment
fipvinfect
monocyt
collect
fip
cat
chloroquin
chang
fipv
n
gene
express
suggest
treatment
cell
alreadi
infect
fipv
chloroquin
induc
antivir
effect
fipvinfect
monocytesmacrophag
major
compon
cell
produc
inflammatori
cytokin
involv
patholog
deterior
regan
et
al
takano
et
al
takano
et
al
studi
chloroquin
significantli
inhibit
inflammatori
cytokin
mrna
express
level
fipvinfect
monocyt
mechan
inhibit
inflammatori
cytokin
mrna
express
chloroquin
still
unclear
weber
levitz
suggest
presenc
lysosomotrop
nonlysosomotrop
mechan
chloroquineinduc
inhibit
tnfa
product
former
inhibit
tnfa
releas
cell
latter
inhibit
tnfa
mrna
express
transcript
suggest
signific
inhibit
inflammatori
cytokin
mrna
express
level
chloroquin
fipvinfect
monocyt
involv
nonlysosomotrop
mechan
howev
recent
paper
jang
et
al
shown
chloroquin
inhibit
tnfa
releas
chang
tnfa
mrna
level
synthesi
tnfa
precursor
reason
discrep
unclear
furthermor
addit
lower
tnfa
mrna
express
express
mrna
decreas
jang
et
al
report
stabil
mrna
decreas
chloroquin
present
studi
mechan
might
decreas
express
cytokin
mrna
chloroquin
administ
oral
intraven
treatment
malaria
howev
oral
intraven
administr
chloroquin
burden
veterinarian
andor
owner
thu
present
studi
chose
subcutan
rout
unfortun
pharmacokinet
data
chloroquin
subcutan
administr
therefor
must
reli
pharmacokinet
data
chloroquin
intraven
administr
examin
similar
condit
studi
aderounmu
et
al
report
pharmacokinet
data
singl
intraven
dose
mgkg
chloroquin
present
studi
subcutan
dose
chloroquin
mgkg
thu
pharmacokinet
data
chloroquin
subcutan
administr
cat
may
similar
report
aderounmu
et
al
administ
chloroquin
clinic
symptom
cat
inocul
fipv
strain
time
administr
establish
base
report
de
grootmijn
et
al
previou
experi
takano
hohdatsu
unpublish
data
therefor
cq
treatment
time
group
b
set
day
inocul
fipv
strain
clinic
score
chloroquinetreat
group
better
chloroquineuntr
group
suggest
chloroquin
therapeut
effect
fip
chloroquin
antivir
effect
fipv
vivo
drug
may
use
treatment
fip
obtain
antivir
effect
necessari
increas
chloroquin
dosag
howev
mention
chloroquin
concentr
increas
sever
side
effect
may
induc
combin
chloroquin
antifipv
agent
overcom
problem
hsieh
et
al
succeed
inhibit
fipv
replic
cell
use
lowcytotox
antivir
agent
necessari
investig
possibl
fip
treatment
combin
chloroquin
agent
conclus
demonstr
chloroquin
inhibitori
effect
replic
fipv
antiinflammatori
effect
also
note
experiment
chloroquin
may
effect
drug
treatment
fip
present
experi
examin
whether
cq
effect
treat
fip
futur
studi
necessari
collect
preclin
data
use
pharmacokinet
data
cq
report
aderounmu
et
al
other
aderounmu
fleckenstein
gustafsson
et
al
ducharm
farinotti
tabl
sequenc
pcr
primer
felin
gapdh
tnfalpha
fcov
n
nucleotid
sequenc
locat
length
